EUMOVATE
EUMOVATE
Discontinued
DIN Number
02214423
Drug Class
Human
Market Date
Jun 25, 2001
Company
HC
glaxosmithkline consumer healthcare ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02214423
AIG Number0113261001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
D07AB01 CLOBETASONE
Product Specifications
Dosage FormOintment
Route of AdministrationTopical
AHFS Classification84:06.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
CLOBETASONE BUTYRATEActive
Strength: 0.05 %
Monograph: CLOBETASONE BUTYRATE